0.6522
Schlusskurs vom Vortag:
$0.6886
Offen:
$0.6863
24-Stunden-Volumen:
134.72K
Relative Volume:
0.47
Marktkapitalisierung:
$29.23M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-3.261
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
+1.87%
1M Leistung:
-44.74%
6M Leistung:
-76.29%
1J Leistung:
-85.18%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
HBIO
Harvard Bioscience Inc
|
0.6501 | 29.23M | 106.79M | -8.73M | 10.81M | -0.20 |
![]()
ISRG
Intuitive Surgical Inc
|
492.61 | 176.29B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
230.94 | 66.56B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
91.34 | 44.95B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
221.02 | 32.81B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
BAX
Baxter International Inc
|
33.74 | 17.41B | 17.28B | 108.00M | 391.00M | 0.20 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
2020-12-09 | Eingeleitet | Northland Capital | Outperform |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2019-07-08 | Herabstufung | Janney | Buy → Neutral |
2018-01-24 | Bestätigt | Janney | Buy |
2018-01-23 | Bestätigt | The Benchmark Company | Buy |
2016-11-17 | Eingeleitet | Singular Research | Buy |
2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa
Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges - Investing.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Harvard Bioscience Reports 2024 Financial Results - TipRanks
Harvard Bioscience Navigates Growth Amid Challenges - TipRanks
Harvard Bioscience secures waiver for credit covenant By Investing.com - Investing.com Australia
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewswire
Harvard Bioscience CEO to Host Fireside Chats at Roth and KeyBanc Healthcare Forums - StockTitan
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire
Earnings call transcript: Harvard Bioscience Q4 2024 beats expectations but faces market challenges - Investing.com
Harvard Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Harvard Bioscience slumps after weak revenue forecast - TradingView
HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Nasdaq
Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year - TipRanks
Harvard Bioscience earnings beat, revenue topped estimates By Investing.com - Investing.com UK
Harvard Bioscience Achieves Profit Turnaround Despite Revenue Challenges in Latest Quarter - StockTitan
Harvard Bioscience IncQ4 2024 Revenues $24.6 Million -March 12, 2025 at 07:04 am EDT - Marketscreener.com
Harvard Bioscience Q4 and Full-Year 2024 Financial Results - TradingView
Harvard Bioscience secures waiver for credit covenant - Investing.com
Harvard BioscienceExploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30 - Marketscreener.com
Costco Price Plunge Equals Opportunity for Investors - The Globe and Mail
Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday - Armenian Reporter
Harvard Bioscience, Inc. to Host Earnings Call - ACCESS Newswire
HBIO stock touches 52-week low at $0.86 amid market challenges - Investing.com Australia
BioAtla Inc (BCAB) shows promising results - US Post News
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences - The Manila Times
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Can These New Research Platforms Transform Toxicology Studies? Harvard Bioscience Reveals Latest Innovations - StockTitan
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience, Inc. to Announce Q4 2024 Financial Results on March 12, 2025 - Nasdaq
How to Access Harvard Bioscience's Critical Q4 2024 Financial Results Call - StockTitan
5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - MSN
NAYA Biosciences Announces Nomination of New Board Members - The Manila Times
Harvard Bioscience stock hits 52-week low at $1.23 By Investing.com - Investing.com Canada
BostInno✈️ Net-zero aviation fuel | MassVentures' deep tech investments - The Business Journals
HBIO stock touches 52-week low at $1.3 amid sharp annual decline - Investing.com Australia
Preclinical Software for Physiology DA and AS Market to Grow by USD 4.38 Billion from 2025-2029, Driven by Bioinformatics Tools in Research, AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Electroporation Instruments Market Growth 2025: Key Industry Trends, Share and Demand by 2033 - WICZ
Harvard Bioscience Inc (HBIO) Stock Sees a-10.84 Decrease - The News Heater
OceanFirst Financial Corp (OCFC) vs. Its Peers: A Comparison - The News Heater
Why Investors Shouldn't Be Surprised By Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 31% Share Price Plunge - Simply Wall St
Harvard Bioscience, Inc. (NASDAQ:HBIO) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough - Simply Wall St
JPMorgan Chase & Co. Makes New $75,000 Investment in WEBTOON Entertainment Inc. (NASDAQ:WBTN) - Defense World
JPMorgan Chase & Co. Boosts Stock Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - Defense World
HBIO stock touches 52-week low at $1.7 amid market challenges - Investing.com India
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in January - MarketBeat
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harvard Bioscience Inc-Aktie (HBIO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Green James W | Chief Executive Officer |
Jun 06 '24 |
Buy |
3.07 |
20,000 |
61,400 |
3,101,091 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):